Clontech Laboratories Joins Forces with Vectalys SAS By CIOReview Team

Clontech Laboratories Joins Forces with Vectalys SAS

CIOReview Team | Thursday, 28 May 2015, 11:30 IST

  •  No Image

Mountain View, CA: Clontech Laboratories has announced that it has partnered with Vectalys SAS to combine Clontech's Living Colors fluorescent protein and Tet-On 3G technologies with Vectalys' expertise in providing the highest quality ready-to-use lentiviral particles as vectors for gene delivery.

Talking about the partnership, Carol Lou, General Manager of Clontech Laboratories said that the strategic alliance with Vectalys would enable Clontech to deliver its solutions at high copy number to various cell type including primary cells. Mentioning about the company, he said that Clontech has been at the forefront of developing viral gene delivery tools such as Lenti-X, Retro-X and Adeno-X.

Somatic cell reprogramming kits as well as lentiviral particles would be the initial product offering. The reprogramming kits are used to generate induced pluripotent stem cells (iPS cells) while lentiviral particles are used for fluorescent labeling of whole cells and of specific subcellular structures.

The company Vectalys relies on highly concentrated and purified lentiviral tools for successful cell transduction. Their collaboration with Clontech’ solutions would offer their customers with unique and optimal gene delivery.

CIO Viewpoint

Leveraging IT to ensure Data Integrity in...

By By Deepak Saini,Director – IT,Dr. Reddys Pharmaceuticals LLC, NAG Region

How Is Technology Disrupting The Pharma And...

By Onkar Kapoor, Group CIO & Head IT, Akums Drugs & Pharmaceuticals Ltd.

CXO Insights

The Growing Importance Of Supply Chain...

By Gustavo Salem, Group President, IDEX Health & Science LLC

A Symbiosis Of Technology And Nature

By Amanda L. Goltz, Vice President, Digital Innovation, BTG

Next-Generation Commercial Data Management...

By Ashwin Athri, SVP, Precision for Value

Facebook